OIG and CMS Seek to Minimize Burdens on Providers and Suppliers During the COVID-19 Pandemic

By Adrienne Dresevic, Esq. and Arturo Trafny, Esq. of The Health Law Partners, P.C.
Recently, both the Centers for Medicare & Medicaid Services (CMS) and the Department of Health and Human Services Office of Inspector General (OIG) have announced that they will be taking certain actions to minimize the burdens imposed on providers and suppliers by the 2019 Novel Coronavirus (COVID-19).

COVID-19 Federal Response Update – Thursday, April 2, 2020

By Capitol Associates, Inc.
Deborah Brix, one of the top coronavirus response advisors to President Trump and Vice President Pence, is asking colleges and universities to develop a special type of blood test to see if healthcare workers have developed an immunity to COVID-19. The enzyme-linked immunosorbent assay (ELISA) tests can detect antibodies that the body naturally produce. These tests are already used to detect antibodies for other infectious diseases such as HIV.